A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. I'm back in ...

President Donald Trump has demanded that pharmaceutical companies such as Pfizer release what he described as hidden COVID-19 vaccine data, raising questions about the legacy of Operation Warp Speed, ...

Valneva SE (NASDAQ: VALN) shared final immunogenicity and safety data on Wednesday from the Phase 2 study, VLA15-221, of the Lyme disease vaccine candidate, VLA15. Lyme disease is a bacterial ...

Please provide your email address to receive an email when new articles are posted on . Nirsevimab and maternal vaccination produced strong increases in RSV neutralizing antibodies in infants.